Brief: SciBase: Study Supports Use Of Nevisense Within New Non-Melanoma Skin Cancer Application

SciBase Holding AB (publ)

05/02/2021 12:02

Feb 5 (Reuters) - SciBase Holding AB (publ)  SCIB.ST :
    * FURTHER STUDY SUPPORTS USE OF NEVISENSE WITHIN NEW NON-MELANOMA SKIN CANCER APPLICATION
    * NEW CLINICAL STUDY FROM GERMANY INCLUDING NEARLY 1,000 PATIENTS CONFIRMS VALUE OF
NEVISENSE WHEN
USED TO EVALUATE SUSPECTED NON-MELANOMA SKIN CANCER
    * STUDY CONFIRMED ABILITY OF NEVISENSE TO ACCURATELY IDENTIFY NON-MELANOMA SKIN CANCERS WITH
A
SENSITIVITY OF 98,4%
    * IN ADDITION, STUDY SHOWED THAT WHEN USING NEVISENSE ALMOST HALF OF LESIONS EXAMINED DID
NOT
REQUIRE A BIOPSY
    * RESULTS SUPPORT A NEW CLINICAL APPLICATION THAT IS AN IMPORTANT PART OF OUR GROWTH
STRATEGY

Source text for Eikon:  ID:nWkrbtTmWJ 
Further company coverage:  SCIB.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))